Arkin Bio Ventures is a Tel Aviv, Israel based venture capital firm founded in 2016. It is a part of Arkin Holdings.
The firm prefers to invest and support early and mid-stage companies that focus on immunotherapy, cancer, metabolism, microbiome, autoimmune diseases, and drug delivery platforms.
The notable investment portfolio of Arkin Bio Ventures includes ARTSaVIT, Keros Therapeutics, Metabomed, Oncorus, Pi Therapeutics, Werewolf Therapeutics. As of January 2020, Arkin Bio Ventures has made 10 investments.
Timeline
Funded Companies
Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug.
People
Pini Orbach Ph.D
Manager
Further reading
Documentaries, videos and podcasts
Companies
ARTSaVIT
Keros Therapeutics
Metabomed
Oncorus
Pi Therapeutics
Werewolf Therapeutics
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 2
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 3
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 4
Aime Anne Nisay
QA Engineer of web and mobile applications - 5
Henry Ogolla
Passionate about reading and writing. - 6
Rachel Phythian
Advisor / Investor